Curaleaf (OTCMKTS:CURLF) Issues Earnings Results, Beats Estimates By $0.17 EPS

Key Points

• Curaleaf reported $0.09 EPS for the quarter, beating the consensus estimate of ($0.08) by $0.17.
• Shares jumped about 6.7% to $3.48 midday on Tuesday with volume around 887,638 shares and a market capitalization of $2.39 billion.
• The company remains unprofitable, posting a negative return on equity of 23.17% and a negative net margin of 18.08%, with a P/E of -11.60 and a debt-to-equity ratio of 1.14.

Curaleaf (OTCMKTS:CURLF - Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.09 EPS for the quarter, beating the consensus estimate of ($0.08) by $0.17, Zacks reports. Curaleaf had a negative return on equity of 23.17% and a negative net margin of 18.08%.

Curaleaf Stock Up 6.7%

OTCMKTS CURLF traded up $0.22 during mid-day trading on Tuesday, hitting $3.48. The company's stock had a trading volume of 887,638 shares, compared to its average volume of 1,034,855. The firm has a market capitalization of $2.39 billion, a price-to-earnings ratio of -11.60 and a beta of 1.58. The company's 50 day simple moving average is $2.50 and its 200 day simple moving average is $2.59. The company has a current ratio of 1.52, a quick ratio of 0.76 and a debt-to-equity ratio of 1.14. Curaleaf has a twelve month low of $0.72 and a twelve month high of $5.05.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company's vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf's product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.